Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A 24-hour Ambulatory Blood Pressure Monitoring Study in Hypogonadal Men Treated With Natesto Nasal Testosterone Gel

NCT04976595 is registered in ClinicalTrials.gov with Acerus Pharmaceuticals Corporation as lead sponsor.

NCT NCT04976595
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04976595 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A 24-hour Ambulatory Blood Pressure Monitoring Study in Hypogonadal Men Treated With Natesto Nasal Testosterone Gel
Lead sponsor
Acerus Pharmaceuticals Corporation
Phase
Phase 4
Overall status
Unknown status
Start date
July 1, 2021
Completion date
December 31, 2022
Enrollment
218 (estimated)
Sites
30

Conditions

As the registry lists them; a condition with its own page is linked.

hypogonadism